Search
for

    Glossary Depression Assessment

    systematic evaluation of depressive symptoms using tools like questionnaires

    A Depression Assessment is a systematic approach used to evaluate the presence and severity of depressive symptoms in an individual. This can involve various tools such as questionnaires, interviews, and standardized tests like the PHQ-9 (Patient Health Questionnaire-9) or the Beck Depression Inventory. These assessments help healthcare professionals diagnose depression, monitor treatment progress, and tailor interventions to the patient's needs.

    Related Terms

    Sort by

    Research 30 of 1000+

    1. Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment Cronfa (Swansea University) · 2026
    2. Assessment of depression and anxiety in trichodynia patients of Telogen effluvium and Alopecia areata International Journal of Medical Research and Health Sciences · 2016
    3. Assessment of a Bidirectional Association Between Major Depressive Disorder and Alopecia Areata JAMA Dermatology · 2019 · 37 citations
    4. Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment Brain Sciences · 2026
    5. An assessment for measuring loneliness, anxiety, and depression in male patients with androgenetic alopecia undergoing hair transplantation surgery: A before‐after study Journal of Cosmetic Dermatology · 2022
    6. Evaluation of Prevalence of PCOS and Associated Depression, Nutrition, and Family History: A Questionnaire-based Assessment. PubMed · 2022
    7. Psychological assessment in 355 Chinese college students with androgenetic alopecia Medicine · 2018 · 11 citations
    8. Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024 PLoS ONE · 2025
    9. Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024 medRxiv (Cold Spring Harbor Laboratory) · 2024
    10. Isolated depressive disorders and suicidality with finasteride use for androgenetic alopecia: a call for enhanced vigilance Therapies · 2025
    11. Dermatologists’ Perspectives and Real-World Assessment of Alopecia Areata Severity, Burden, and Healthcare Resource Utilization in Adults in the United Arab Emirates Dermatology and Therapy · 2026
    12. Dermatologists’ Perspectives and Real-World Assessment of Alopecia Areata Severity, Burden, and Healthcare Resource Utilization in Adults in the Kingdom of Saudi Arabia Dermatology and Therapy · 2026
    13. The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit–risk assessment of finasteride and dutasteride Journal of Dermatological Treatment · 2013 · 66 citations
    14. Update on Hidradenitis Suppurativa (Part I): Epidemiology, Pathogenesis, Severity assessment and Comorbidities Revista da Sociedade Portuguesa de Dermatologia e Venereologia · 2018 · 1 citations
    15. The hidden burden of visibility: Social appearance anxiety in patients with alopecia areata – A comparative cross-sectional study Journal of Health Psychology · 2025 · 1 citations
    16. P136 Psychological impact of hair loss in women: a qualitative systematic review British Journal of Dermatology · 2025
    17. Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review Dermatology and Therapy · 2021 · 67 citations
    18. Assessment of Psychosocial Dimensions of Systemic lupus Erythematosus (SLE): Implications for the Health Care Professionals 2023
    19. Family functioning, psychopathology and quality of life in children and adolescents with alopecia areata Journal of Dr Behcet Uz Children s Hospital · 2016
    20. The Assessment and Treatment of Geezers JAMA · 1988
    21. Alopesi Areata ile Depresyon İlişkisi Ayna Klinik Psikoloji Dergisi · 2023 · 1 citations
    22. Depressive and Anxiety Symptoms in Women with Polycystic Ovary Syndrome: A Meta-Analysis Journal of Clinical Medicine · 2026
    23. Assessment of Serum Level of Brain-Derived Neurotrophic Factor (BDNF) In Pediatric Alopecia Areata: A Case - Control Study 2025
    24. Assessment of the Vitamin D Levels in the Patients Presenting with Different Medical Conditions and its Correlation with Symptomatology Annals of King Edward Medical University · 2009 · 3 citations
    25. Alopecia areata and health-related quality of life: a systematic review and meta-analysis British Journal of Dermatology · 2016 · 128 citations
    26. Clinician vs Self-ratings of Hirsutism in Patients With Polycystic Ovarian Syndrome JAMA dermatology · 2016 · 52 citations
    27. Putative role for insulin resistance in depression risk in polycystic ovary syndrome Fertility and Sterility · 2015 · 46 citations
    28. Alopecia Areata and Its Association With Anxiety and Depression: A Case–Control Study in Patients Referred to Dermatology Clinics International Journal of Clinical Practice · 2026
    29. Assessing Causality Between Androgenetic Alopecia with Depression: A Bidirectional Mendelian Randomization Study Clinical Cosmetic and Investigational Dermatology · 2025
    30. SP0158 Assessment and management of SLE in a nurse led clinic Annals of the Rheumatic Diseases · 2013